These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differential effects of retinoic acid (RA) and N-(4-hydroxyphenyl) retinamide (4-HPR) on cell growth, induction of differentiation, and changes in p34cdc2, Bcl-2, and actin expression in the human promyelocytic HL-60 leukemic cells. Dipietrantonio A; Hsieh TC; Wu JM Biochem Biophys Res Commun; 1996 Jul; 224(3):837-42. PubMed ID: 8713132 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation. Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799 [TBL] [Abstract][Full Text] [Related]
5. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid. Delia D; Aiello A; Lombardi L; Pelicci PG; Grignani F; Grignani F; Formelli F; Menard S; Costa A; Veronesi U Cancer Res; 1993 Dec; 53(24):6036-41. PubMed ID: 8261419 [TBL] [Abstract][Full Text] [Related]
6. Biotransformation and protein binding of N-(4-hydroxyphenyl)retinamide in murine mammary epithelial cells. Bunk MJ; Kinahan JJ; Sarkar NH Cancer Lett; 1985 Apr; 26(3):319-26. PubMed ID: 2986832 [TBL] [Abstract][Full Text] [Related]
7. Retinoid metabolism in the prostate: effects of administration of the synthetic retinoid N-(4-hydroxyphenyl)retinamide. Lewis KC; Hochadel JF Cancer Res; 1999 Dec; 59(23):5947-55. PubMed ID: 10606240 [TBL] [Abstract][Full Text] [Related]
8. Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites. Sabichi AL; Xu H; Fischer S; Zou C; Yang X; Steele VE; Kelloff GJ; Lotan R; Clifford JL Clin Cancer Res; 2003 Oct; 9(12):4606-13. PubMed ID: 14555536 [TBL] [Abstract][Full Text] [Related]
9. Effects of pretreatment with the retinoid N-(4-hydroxyphenyl)-all-trans-retinamide and phenobarbital on the disposition and metabolism of N-(4-hydroxyphenyl)-all-trans-retinamide in mice. Hultin TA; McCormick DL; May CM; Moon RC Drug Metab Dispos; 1988; 16(6):783-8. PubMed ID: 2907453 [TBL] [Abstract][Full Text] [Related]
10. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines. Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676 [TBL] [Abstract][Full Text] [Related]
11. Distribution and metabolism of the retinoid, N-(4-methoxyphenyl)-all-trans-retinamide, the major metabolite of N-(4-hydroxyphenyl)-all-trans-retinamide, in female mice. Hultin TA; Filla MS; McCormick DL Drug Metab Dispos; 1990; 18(2):175-9. PubMed ID: 1971569 [TBL] [Abstract][Full Text] [Related]
12. Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy. McCormick DL; Mehta RG; Thompson CA; Dinger N; Caldwell JA; Moon RC Cancer Res; 1982 Feb; 42(2):508-12. PubMed ID: 6459843 [TBL] [Abstract][Full Text] [Related]
13. Hormonal induction of mammary tumor viruses and its implications for carcinogenesis. McGrath CM; Jones RF Cancer Res; 1978 Nov; 38(11 Pt 2):4112-25. PubMed ID: 212187 [TBL] [Abstract][Full Text] [Related]
14. N-(4-hydroxyphenyl)-all-trans-retinamide pharmacokinetics in female rats and mice. Hultin TA; May CM; Moon RC Drug Metab Dispos; 1986; 14(6):714-7. PubMed ID: 2877832 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of aberrant proliferation and induction of apoptosis in HER-2/neu oncogene transformed human mammary epithelial cells by N-(4-hydroxyphenyl)retinamide. Jinno H; Steiner MG; Mehta RG; Osborne MP; Telang NT Carcinogenesis; 1999 Feb; 20(2):229-36. PubMed ID: 10069458 [TBL] [Abstract][Full Text] [Related]
16. [Inhibitory effects on hepatocarcinoma and B16 melanoma cells by N-(4-hydrophenyl) retinamide]. Zhang L; Wu XZ Shi Yan Sheng Wu Xue Bao; 2003 Dec; 36(6):421-7. PubMed ID: 14724932 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of mammary tumorigenesis in nulliparous C3H mice by chronic feeding of the synthetic retinoid, N-(4-hydroxyphenyl)-retinamide. Welsch CW; DeHoog JV; Moon RC Carcinogenesis; 1983 Sep; 4(9):1185-7. PubMed ID: 6224605 [TBL] [Abstract][Full Text] [Related]
19. Apoptosis and restriction of G(1)/S cell cycle by fenretinide in Burkitt's lymphoma mutu I cell line accessed with bcl-6 down-regulation. Hsieh T; Wu JM Biochem Biophys Res Commun; 2000 Oct; 276(3):1295-301. PubMed ID: 11027625 [TBL] [Abstract][Full Text] [Related]
20. Induction of endogenous mammary tumor virus expression during hormonal induction of mammary adenoacanthomas and carcinomas of BALB/c female mice. McGrath CM; Prass WA; Maloney TM; Jones RF J Natl Cancer Inst; 1981 Oct; 67(4):841-52. PubMed ID: 6268884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]